Sanofi

Who: Sanofi and Adagene. What: The French drugmaker has decided to exercise an option on a third discovery program with its China/US partner and further invest in Adagene to help advance muzastotug

Moderna appears to have a pathway to approval for its investigational influenza/COVID-19 combination vaccine mRNA-1083 now that it reported positive Phase III efficacy data on June 30 for mRNA-1010, a

Unicycive has already identified a new manufacturing vendor, the company said, which could help it quickly resolve a complete response letter issued by the US Food and Drug Administration for oxylanth

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis Inks Four-Year Proteome Resear